ADOPTIVE CELL THERAPY: CURRENT ADVANCES

ADOPTIVE CELL THERAPY: CURRENT ADVANCES

The immune system plays an important role in the development and treatment of many cancer types. This fact determined the emergence of numerous immunotherapeutic approaches, including that of adoptive cell therapy (ACT). In this article, we set out to describe the basic methods of adoptive cell canc...

Bibliografiset tiedot
Päätekijät:	T. V. Shamova, A. O. Sitkovskaya, L. N. Vashchenko, E. E. Kechedzhieva
Aineistotyyppi:	Artikkeli
Kieli:	Russian
Julkaistu:	ANO "Perspective of oncology" 2020-03-01
Sarja:	Южно-Российский онкологический журнал
Aiheet:	oncology cancer immunotherapy adoptive cell therapy tumour-infiltrating lymphocytes dendritic cells vaccines cytokine-induced killers
Linkit:	https://www.cancersp.com/jour/article/view/40

Samankaltaisia teoksia

Efficiency of ADOPTIVE immunotherapy for melanoma: a case REPORT
Tekijä: E. V. Abakushina, et al.
Julkaistu: (2016-11-01)

Clinical Applications of Combined Immunotherapy Approaches in Gastrointestinal Cancer: A Case-Based Review
Tekijä: Yesim Eralp, et al.
Julkaistu: (2023-09-01)

Combined immunotherapy with dendritic cells and cytokine-induced killer cells for solid tumors: a systematic review and meta-analysis of randomized controlled trials
Tekijä: Wendi Jiang, et al.
Julkaistu: (2024-12-01)

Recent advances in immunotherapy for hepatocellular cancer
Tekijä: LH Butterfield
Julkaistu: (2007-02-01)

Exploring cellular immunotherapy platforms in multiple myeloma
Tekijä: Manh-Cuong Vo, et al.
Julkaistu: (2024-03-01)

Case report: Dendritic cell-cytokine induced killer cell therapy in subjects with chronic lymphocytic leukemia and peritoneal cancer
Tekijä: Brian Mehling, et al.
Julkaistu: (2023-10-01)

Adoptive cell therapy for cancer treatment
Tekijä: Shi Du, et al.
Julkaistu: (2023-08-01)

Characteristics of lymphocyte subpopulations in the peripheral blood and lymph nodes of patients with ovarian cancer
Tekijä: I. Zh. Shubina, et al.
Julkaistu: (2014-11-01)

Cytokine-induced killer cell treatment is superior to chemotherapy alone in esophageal cancer
Tekijä: Jiayang Sun, et al.
Julkaistu: (2023-06-01)

Comparing the efficacy of combined versus single immune cell adaptive therapy targeting colorectal cancer
Tekijä: Denis Nchang Che, et al.
Julkaistu: (2024-04-01)

Cytokine Induced Killer (CIK) Cells Based Adoptive Immunotherapy
Tekijä: S Timalsena, et al.
Julkaistu: (2018-08-01)

The potential and promise for clinical application of adoptive T cell therapy in cancer
Tekijä: Yinqi Li, et al.
Julkaistu: (2024-05-01)

CIK Cell Therapy for Solid Tumor
Tekijä: Jingjing Zhang, et al.
Julkaistu: (2014-06-01)

The Emerging Role of Induced Pluripotent Stem Cells as Adoptive Cellular Immunotherapeutics
Tekijä: Vedika Mehra, et al.
Julkaistu: (2023-11-01)

Application of adoptive cell therapy in malignant melanoma
Tekijä: Qianrong Hu, et al.
Julkaistu: (2025-01-01)

Advances and prospects in tumor infiltrating lymphocyte therapy
Tekijä: Xu Qiu, et al.
Julkaistu: (2024-11-01)

Preclinical evaluation of DC-CIK cells as potentially effective immunotherapy model for the treatment of glioblastoma
Tekijä: Annika Simone Lück, et al.
Julkaistu: (2025-01-01)

Natural killer cell memory: challenges and opportunities for cancer immunotherapy
Tekijä: Yuhua Qu, et al.
Julkaistu: (2024-12-01)

NK cell transfer overcomes resistance to PD-(L)1 therapy in aged mice
Tekijä: Junlei Hou, et al.
Julkaistu: (2024-05-01)

An in vitro investigation into the cytotoxic impact of antigen-presenting dendritic cell-tumor infiltrating lymphocytes on ovarian cancer cells
Tekijä: Shengnan Yang, et al.
Julkaistu: (2024-11-01)

The Advantages and Challenges of Anticancer Dendritic Cell Vaccines and NK Cells in Adoptive Cell Immunotherapy
Tekijä: Elena V. Abakushina, et al.
Julkaistu: (2021-11-01)

First step results from a phase II study of a dendritic cell vaccine in glioblastoma patients (CombiG-vax)
Tekijä: Laura Ridolfi, et al.
Julkaistu: (2024-08-01)

Erratum: First step results from a phase II study of a dendritic cell vaccine in glioblastoma patients (CombiG-vax)
Tekijä: Frontiers Production Office
Julkaistu: (2024-09-01)

Morphology of the immune cells in the wall of the human uterine tube and their possible impact on reproduction—uterine tube as a possible immune privileged organ
Tekijä: Kristína Visnyaiová, et al.
Julkaistu: (2024-03-01)

Comparative assessment of autologous and allogeneic iNKT cell transfer in iNKT cell-based immunotherapy
Tekijä: Mariko Takami, et al.
Julkaistu: (2024-08-01)

Adoptive T Cell Therapy for Solid Tumors: Pathway to Personalized Standard of Care
Tekijä: Shuyang S. Qin, et al.
Julkaistu: (2021-04-01)

Anti-CD137 agonist antibody–independent and clinically feasible preparation of tumor-infiltrating lymphocytes from soft tissue sarcoma and osteosarcoma
Tekijä: Yining Jin, et al.
Julkaistu: (2025-03-01)

Antiviral Cell Products against COVID-19: Learning Lessons from Previous Research in Anti-Infective Cell-Based Agents
Tekijä: Irina Chikileva, et al.
Julkaistu: (2022-04-01)

Limited Clinical Efficacy with Potential Adverse Events in a Pilot Study of Autologous Adoptive Cell Therapy in Canine Oral Malignant Melanoma
Tekijä: Yuan-Yuan Xia, et al.
Julkaistu: (2024-03-01)

LTX-315 and adoptive cell therapy using tumor-infiltrating lymphocytes generate tumor specific T cells in patients with metastatic soft tissue sarcoma
Tekijä: Morten Nielsen, et al.
Julkaistu: (2024-12-01)

Adoptive cell therapy with tumor-infiltrating lymphocytes in combination with nivolumab in patients with advanced melanoma
Tekijä: D. König, et al.
Julkaistu: (2024-12-01)

Feasibility of combination of Gun-Chil-Jung and cytokine-induced killer cells-based immunotherapy for terminal hepatocellular carcinoma patient: a case report
Tekijä: Chan-Ran Park, et al.
Julkaistu: (2023-08-01)

Optimizing tumor-associated antigen-stimulated autologous dendritic cell and cytokine-induced killer cell coculture to enhance cytotoxicity for cancer immunotherapy in manufacturing
Tekijä: Yi-Yen Lee, et al.
Julkaistu: (2023-06-01)

Long-term survival after immunotherapy and targeted therapy without chemotherapy in an elderly patient with HER2-positive gastroesophageal junction cancer: A case report
Tekijä: Wei-Ling Li, et al.
Julkaistu: (2022-11-01)

Contradictory Effect of Lymphocyte Therapy and Prednisolone Therapy on CD3+CD8+CD56+ Natural Killer T Population in Women with Recurrent Spontaneous Abortion
Tekijä: Fatemeh Rezayat, et al.
Julkaistu: (2023-07-01)

How can Cytokine-induced killer cells overcome CAR-T cell limits
Tekijä: Elisa Cappuzzello, et al.
Julkaistu: (2023-08-01)

Current status of cytokine-induced killer cells and combination regimens in breast cancer
Tekijä: Yuancong Jiang, et al.
Julkaistu: (2025-02-01)

Cytokines impact natural killer cell phenotype and functionality against glioblastoma in vitro
Tekijä: Minna Sivonen, et al.
Julkaistu: (2023-09-01)

Current state and prospects of using dendritic cell vaccination for cancer immunotherapy
Tekijä: I.Yu. Filin, et al.
Julkaistu: (2022-09-01)

Regulatory T Cells but Not Tumour-Infiltrating Lymphocytes Correlate with Tumour Invasion Depth in Basal Cell Carcinoma
Tekijä: Paranita Ferronika, et al.
Julkaistu: (2022-11-01)